Hanwha Chemical undertakes phase 1 trial for generic Embrel

Published: 2010-08-23 07:00:00
Updated: 2010-08-23 07:00:00
Hanwha Chemical Co. said it has succeeded in conducting Phase 1 local trials for its generic Embrel with positive results.

The company has a plan to conduct the next clinical trials in cooperation with its affiliated company Dream Pharma, saying the commercialization of its generic product wil...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.